xAnts

FDA approves Johnson & Johnson's ketamine-derived nasal spray for depression as standalone treatment

2025-01-23Fortune

FDA approves Johnson & Johnson's ketamine-derived nasal spray for depression as standalone treatment

The announcement was welcome news for those with major depressive disorder, affecting an estimated 8.3% of the adult population. ...Read more

Recommendations

UK Government Urged to Speed Up Health Benefit Reforms Amid Soaring Costs
2025-01-20Daily Record
FDA approves Johnson & Johnson's ketamine-derived nasal spray for depression as standalone treatment
2025-01-23Fortune on MSN.com
Thomas Tighe Looks Back on 24 Years of Leading Direct Relief in Global Health
2025-01-20The Associated Press on MSN.com
Toxic Chemicals Released in Moss Landing Battery Plant Fire Spark Health Fears
2025-01-18KSBW Monterey-Salinas on MSN.com
2025 will be pivotal for health industry start ups - opinion
2025-01-23The Jerusalem Post Blogs
Breakthrough Study: Ozempic and GLP-1 Drugs Reduce Risk of 42 Health Conditions, Including Heart Attacks and Alzheimer's
2025-01-20AOL
Remembering Stefan: Parents Create Mental Health Quilt to Support Young Minds
2025-01-20BBC
Chris Kamara's Latest Health Update: 'It Hasn't Made Much Difference' After New Initiative
2025-01-20Daily Express
RFK Jr. says he's resigned from anti-vaccine nonprofit as he seeks nation's top health official job
2025-01-23The Associated Press on MSN.com
These are the most critical health crises facing the world in 2025
2025-01-20Euronews

Loading...